Dyspnea and respiratory muscle strength in end-stage liver disease

Table 2 Serum laboratory data of the 40 patients with end-stage liver disease stratified according to the presence or absence of ascites

	All patients (n = 40)	Ascites (n = 17)	Non-ascites (n = 23)	P value
INR	1.40 ± 0.31	1.53 ± 0.34	1.30 ± 0.25	0.0171
Haemoglobin, g/L	121.00 ± 23.80	108.60 ± 24.00	130.10 ± 19.20	0.003
Creatinine, mg/dL	1.19 ± 1.02	1.43 ± 1.49	1.01 ± 0.39	0.3281
Total protein, g/L	72.20 ± 8.70	68.80 ± 8.80	74.70 ± 7.90	0.032
Albumin, g/L	34.80 ± 6.70	32.00 ± 6.90	37.00 ± 5.90	0.019
Total bilirubin, mg/dL	4.67 ± 9.61	6.68 ± 11.41	3.19 ± 7.97	0.0041
Sodium, mmol/L	137.00 ± 5.00	134.00 ± 5.00	139.00 ± 4.00	< 0.001

Values obtained maximum ± 7 d of respiratory tests day.

¹Mann-Whitney rank sum test was used. Statistical significance tested with Student’s t test between ascites and non-ascites groups. INR: International normalised ratio for prothrombin time.